Concepedia

Raghuveer Ramachandra

RR

Statistics

Publications

14

Citations

552

H-Index

12

Active since

2006

Affiliations

Aurigene Discovery Technologies (India)(Current)

West Virginia University

National Center for Cool and Cold Water Aquaculture

National Cancer Institute

Advaxis (United States)

Raghuveer Ramachandra is an author at Aurigene Discovery Technologies (India) specializing in pharmacology, immunotherapy, and cancer immunotherapy.

Publications per year

2006–2021

14

Publications

14

PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

Pottayil G. Sasikumar, Naremaddepalli S. Sudarshan, Srinivas Adurthi et al. · Communications Biology · 2021 · 149 citations · Full text

, , +17

Cloning and characterization of microRNAs from rainbow trout (Oncorhynchus mykiss): Their expression during early embryonic development

Raghuveer Ramachandra, Mohamed Salem, Scott A. Gahr et al. · BMC Developmental Biology · 2008 · 109 citations · Full text

, , +17

A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy

Pottayil G. Sasikumar, Raghuveer Ramachandra, Srinivas Adurthi et al. · Molecular Cancer Therapeutics · 2019 · 63 citations · Full text

, , +17

Molecular characterization and expression profiles of cyclin B1, B2 and Cdc2 kinase during oogenesis and spermatogenesis in rainbow trout (Oncorhynchus mykiss)

Gao‐Feng Qiu, Raghuveer Ramachandra, Caird E. Rexroad et al. · Animal Reproduction Science · 2007 · 51 citations

, , +13

Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus

C. N. Prashantha, Kuruvalli Gouthami, L Lavanya et al. · Journal of Molecular Graphics and Modelling · 2020 · 35 citations · Full text

, , +16

1–5 of 14